Similar articles

• Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.

  Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P. Dello Russo NM, et al. Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):146-53. Int J Oral Maxillofac Implants. 2007. PMID: 17340909 No abstract available.
• Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

  Ruggiero SL, Fantasia J, Carlson E. Ruggiero SL, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41. doi: 10.1016/j.tripleo.2006.06.004. Epub 2006 Jul 31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006. PMID: 16997108 No abstract available.
• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

  Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. J Oral Maxillofac Surg. 2007 Mar;65(3):369-76. doi: 10.1016/j.joms.2006.11.003. J Oral Maxillofac Surg. 2007. PMID: 17307580 No abstract available.
• [Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase?].

  Urade M. Urade M. Clin Calcium. 2010 Nov;20(11):1740-3. Clin Calcium. 2010. PMID: 21066911 Review. Japanese. No abstract available.
• Bisphosphonates and bisphosphonate induced osteonecrosis.

  Sawatari Y, Marx RE. Sawatari Y, et al. Oral Maxillofac Surg Clin North Am. 2007 Nov;19(4):487-98, v-vi. doi: 10.1016/j.coms.2007.07.003. Oral Maxillofac Surg Clin North Am. 2007. PMID: 18088900 Review.